tirzepatide first dose What is the Starting for Weight Loss? First dose today! : r/Zepbound

Aug 28, 2025 Hydroxychloroquine use was linked to diverse psychiatric adverse drug effects A systematic review found that hydroxychloroquine (HCQ) may induce psychiatric side effects such as psychosis Aug 26, 2025 Osteoarthritis linked to increased risk of incident sleep apnea A large cohort study found that individuals with knee, hip, or hand osteoarthritis (OA) have a significantly increased Aug 21, 2025 Proper asthma management essential for healthy pregnancy outcomes Asthma in pregnancy poses risks such as preeclampsia, preterm labor, low birth weight, and neonatal respiratory issues, Aug 19, 2025 Neural changes after digital games in children with math difficulties A study on children at risk for developmental dyscalculia found that a digital math intervention enhanced brain Aug 14, 2025 Nanotechnology-based Tranexamic acid microemulsion effective for melasma treatment A clinical study on melasma treatment found that topical TXA 1% microemulsion monotherapy was as effective and safe as Aug 12, 2025 Whitening toothpastes maintained tooth color after bleaching A laboratory study evaluated the impact of various whitening toothpastes on teeth post in-office bleaching with 40% Aug 7, 2025 Persistent fatty liver disease increased diabetes and heart disease risk A large Korean cohort study found that persistent MASLD significantly increased the risk of developing type 2 diabetes Aug 5, 2025 Calcium channel blocker use lowered acute infection risk versus alternatives A cohort study using UK data found that amlodipine users had a significantly lower risk of acute infections and Jul 31, 2025 Saline irrigation enhanced nasal corticosteroid efficacy for rhinitis management A randomized clinical trial compared intranasal corticosteroids alone versus in combination with nasal saline Jul 29, 2025 Serum lipid and plasma fatty acid profiles in PTSD patients and healthy individuals A recent study highlights significant differences in lipid and fatty acid profiles between PTSD patients and healthy

3 A refresher on the SELECT trial As a refresher, the SELECT trial represented the first efforts to specifically investigate cardiovascular (CV) endpoints with GLP-1 receptor agonist medications

It reported favorable outcomes for all primary and secondary measures, including ADAS-Cog14, AD Composite Score (ADCOMS), and ADCS-MCI-ADL scores [43]

It is generally recommended to avoid or significantly limit alcohol while taking tirzepatide

Conclusion GLP-1 agonists are proving to be more than just a tool for managing diabetes and obesity

The slowed gut motility that helps with weight loss also slows bowel movements